Healthcare Industry News: TomoHD
News Release - January 24, 2011
Swedish Cancer Institute Installs First TomoTherapy(R) Radiation Therapy System in Seattle Metropolitan AreaIntroduction of TomoTherapy Treatments at New Ballard, Wash. Facility Delivers Flexibility in Treating Wide Range of Cancers
MADISON, WI--(Healthcare Sales & Marketing Network) - TomoTherapy Incorporated (NASDAQ:TOMO ), maker of advanced radiation therapy solutions for the treatment of cancer and other diseases, today announced that Swedish Cancer Institute (SCI) has installed the first TomoTherapy® radiation therapy system in the Seattle area at its new, community-based Radiation Treatment Center on the Ballard, Wash. campus.
"We selected the TomoTherapy system because it's a promising technology with many advantages -- from the complete integration of treatment planning, imaging and treatment delivery, to its flexibility in treating a wide range of cancers," said Dan Landis, M.D., Ph.D., the lead physician at the SCI facility on the Swedish/Ballard campus. "In a large system like ours, we want to be able to offer our patients the very best care in every situation, and TomoTherapy technology gives us the ability to do so."
The TomoTherapy radiation therapy system is the only one of its kind to be built on a CT imaging platform, which allows clinicians to see the tumor immediately before treatment and adjust radiation delivery in real-time. The ring-like design enables helical delivery of radiation from all angles around a patient, and features beam-shaping technology specifically designed for delivering intensity-modulated radiation therapy (IMRT). These features provide clinicians with greater control of how they can conform radiation delivery to complex tumors, while minimizing damage to surrounding healthy tissues.
The TomoTherapy system introduces the first fully integrated process for radiation therapy, combining easy-to-use software for treatment planning, quality assurance, patient set-up and treatment delivery from a centralized database. Because all patient and treatment plan information is stored in a single, secure location, the risk of data transfer errors is minimized. To further enhance safety, an enclosure surrounds the rotating gantry and associated components so these moving parts cannot come in contact with the patient or therapist.
Swedish Cancer Institute also will be using the TomoTherapy system's TomoDirect™ capabilities at the Ballard campus. The TomoDirect radiation delivery mode is a non-rotational delivery option that enables clinicians to quickly plan and deliver advanced radiation treatments by applying multiple, carefully directed radiation beams to the target area.
"Our long-term goal has been to more fully develop cancer-care capabilities for patients in the northwest Seattle area," said Albert B. Einstein Jr., M.D., executive director of SCI. "The recent expansion and redevelopment of our Ballard campus, and the addition of the TomoTherapy system there, is giving our patients an opportunity to conveniently receive the most advanced cancer care closer to home."
"Swedish Cancer Institute is one of the premier cancer institutions in the Pacific Northwest and we are pleased to be partnering with them to bring the advantages of the TomoTherapy system to the Seattle area," said Fred Robertson, M.D., TomoTherapy's CEO.
About Swedish Cancer Institute
The Swedish Cancer Institute (SCI) opened in 1932 as the first dedicated cancer-care center west of the Mississippi. It is the largest and most comprehensive cancer treatment program in the Pacific Northwest, caring for more people with more types of cancer than any other provider in the region. The Institute has a presence on all four of Swedish's hospital campuses -- First Hill, Cherry Hill, Ballard and Edmonds -- as well as in East King County and at Highline Medical Center in Burien. A true multidisciplinary institute, SCI offers a wide range of advanced cancer-treatment options in chemotherapy, radiation therapy and surgery -- backed by extensive diagnostic capabilities, patient education and support-group services. For more information, visit www.swedish.org/cancer.
About TomoTherapy Incorporated
TomoTherapy Incorporated develops, markets and sells advanced radiation therapy solutions that can be used to treat a wide variety of cancers, from the most common to the most complex. The ring gantry-based TomoTherapy® platform combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. TomoTherapy's suite of solutions include its flagship Hi--Art® treatment system, which has been used to deliver more than three million CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions; the TomoHD™ treatment system, designed to enable cancer centers to treat a broader patient population with a single device; and the TomoMobile™ relocatable radiation therapy solution, designed to improve access and availability of state-of-the-art cancer care. TomoTherapy's stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.
©2011 TomoTherapy Incorporated. All rights reserved. TomoTherapy, Tomo, Hi--Art, TomoHD, TomoDirect, TQA, the TomoTherapy logo are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated in the United States and other countries.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.